US20030187247A1
(en)
*
|
1992-09-30 |
2003-10-02 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
US5652138A
(en)
*
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
PT744958E
(pt)
|
1994-01-31 |
2003-11-28 |
Univ Boston |
Bancos de anticorpos policlonais
|
US20060078561A1
(en)
*
|
1994-01-31 |
2006-04-13 |
The Trustees Of Boston University |
Polyclonal antibody libraries
|
US6193982B1
(en)
|
1995-04-27 |
2001-02-27 |
The United States Of America As Represented By The Department Of Health & Human Services |
Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
|
US7048935B2
(en)
|
1995-04-27 |
2006-05-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
|
US6987096B1
(en)
|
1995-04-27 |
2006-01-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
|
US5843882A
(en)
|
1995-04-27 |
1998-12-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antiviral proteins and peptides
|
US6428790B1
(en)
|
1995-04-27 |
2002-08-06 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services |
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
|
US6780847B2
(en)
|
1995-04-27 |
2004-08-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
|
US6265215B1
(en)
|
1996-09-13 |
2001-07-24 |
Ludwig Institute For Cancer Research |
Isolated peptides which complex with HLA-Cw16 and uses thereof
|
ES2233065T3
(es)
|
1998-07-13 |
2005-06-01 |
Board Of Regents, The University Of Texas System |
Utilizacion de anticuerpos anti-aminofosfolipidos para el tratamiento del cancer.
|
EP1141314A2
(en)
|
1998-12-31 |
2001-10-10 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
US7883704B2
(en)
*
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
US6482928B1
(en)
*
|
1999-04-13 |
2002-11-19 |
Aventis Pasteur Limited And University Of Toronto |
Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5
|
AU2001281747A1
(en)
*
|
2000-08-02 |
2002-02-13 |
H:S Hvidovre Hospital |
Composition and method for the treatment or prevention of hiv infection
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
AU2002254382B2
(en)
|
2001-03-22 |
2007-02-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Glycosylation-resistant and nonglycosylated cyanovirins
|
US20020146753A1
(en)
*
|
2001-04-06 |
2002-10-10 |
Henrik Ditzel |
Autoantibodies to glucose-6-phosphate isomerase and their participation in autoimmune disease
|
WO2002090510A2
(en)
*
|
2001-05-08 |
2002-11-14 |
Emory University |
Regulating immine responses using dendritic cells
|
JP5033303B2
(ja)
|
2001-07-05 |
2012-09-26 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
抗原性c型hivポリペプチドをコードするポリヌクレオチド、ポリペプチドおよびそれらの使用
|
DE60237704D1
(de)
*
|
2001-10-16 |
2010-10-28 |
Government Of The Us Secretary |
Neutralisierende antikörper gegen hiv mit breiter kreuzreaktion, die mit hilfe von env-cd4-co-rezeptorkomplexen selektiert werden
|
WO2003065997A2
(en)
|
2002-02-06 |
2003-08-14 |
Vicor Technologies, Inc. |
Anti-infarction molecules
|
US7939641B2
(en)
|
2002-04-09 |
2011-05-10 |
The Scripps Research Institute |
Motif-grafted hybrid polypeptides and uses thereof
|
EP1504034B1
(en)
*
|
2002-05-06 |
2012-12-12 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
|
EP1554392A4
(en)
*
|
2002-05-06 |
2007-08-08 |
Us Gov Health & Human Serv |
IDENTIFICATION OF WIDE-NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES WITH CROSS-REACTION USING SEQUENTIAL PLATE ADHESION METHOD OF ANTIGENS OF PHAGE PRESENTATION BANKS
|
US7429360B2
(en)
*
|
2002-05-28 |
2008-09-30 |
Autogenomics, Inc. |
Level-controlled pipette for automated analytic devices
|
AU2003243151A1
(en)
*
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
WO2004048936A2
(en)
*
|
2002-11-26 |
2004-06-10 |
University Of Utah Research Foundation |
Microporous materials, methods, and articles for localizing and quantifying analytes
|
US7597936B2
(en)
*
|
2002-11-26 |
2009-10-06 |
University Of Utah Research Foundation |
Method of producing a pigmented composite microporous material
|
WO2004053100A2
(en)
*
|
2002-12-11 |
2004-06-24 |
The Scripps Research Institute |
Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same
|
ATE442861T1
(de)
|
2003-03-07 |
2009-10-15 |
Univ Texas |
Gegen antikörper gerichtete photodynamische therapie
|
JP2007515394A
(ja)
*
|
2003-05-06 |
2007-06-14 |
ザ スクリプス リサーチ インスティチュート |
ドメイン交換結合分子、その使用方法および製造方法
|
US20060035242A1
(en)
*
|
2004-08-13 |
2006-02-16 |
Michelitsch Melissa D |
Prion-specific peptide reagents
|
JP2007518422A
(ja)
|
2004-01-21 |
2007-07-12 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
変異体ナトリウムチャンネルNaν1.7およびそれに関連する方法
|
EP1714152A4
(en)
*
|
2004-02-09 |
2008-08-13 |
Univ Northeastern |
Monoclonal antibody-based biomarker detection and development platform
|
WO2006044410A2
(en)
*
|
2004-10-14 |
2006-04-27 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines
|
EP1807450A2
(en)
*
|
2004-10-29 |
2007-07-18 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
|
US20080248063A1
(en)
|
2004-12-29 |
2008-10-09 |
Seattle Biomedical Research Institute |
Hetero-Oligomeric Hiv Envelope Proteins
|
NZ587255A
(en)
*
|
2005-01-13 |
2012-03-30 |
Novartis Vaccines & Diagnostic |
Elisa assays using prion-specific peptide reagents
|
WO2006076683A2
(en)
*
|
2005-01-13 |
2006-07-20 |
Novartis Vaccines And Diagnostics Inc. |
Isolation and detection of pathogenic prions
|
AU2007207544A1
(en)
|
2006-01-17 |
2007-07-26 |
Health Research, Inc. |
Heteroduplex tracking assay
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
US9365622B2
(en)
*
|
2006-03-01 |
2016-06-14 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
US7492312B2
(en)
*
|
2006-11-14 |
2009-02-17 |
Fam Adly T |
Multiplicative mismatched filters for optimum range sidelobe suppression in barker code reception
|
CA2674378A1
(en)
*
|
2007-01-03 |
2008-07-17 |
Burnham Institute For Medical Research |
Methods and compositions related to clot binding compounds
|
ATE525484T1
(de)
|
2007-01-08 |
2011-10-15 |
Us Gov Health & Human Serv |
Slco1b3-genotyp
|
EP2117303A4
(en)
|
2007-01-16 |
2011-06-08 |
Abbott Lab |
METHOD FOR THE TREATMENT OF DANDRUFFS
|
CN101679507A
(zh)
|
2007-03-29 |
2010-03-24 |
艾博特公司 |
结晶抗人类il-12抗体
|
EP2478766A3
(en)
|
2007-05-09 |
2012-08-15 |
Burnham Institute for Medical Research |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
CN101688194B
(zh)
|
2007-05-23 |
2013-09-11 |
Uab研究基金会 |
去毒的肺炎球菌神经氨酸酶及其用途
|
US20100239596A1
(en)
*
|
2007-08-22 |
2010-09-23 |
University Of Southern California |
Grp78 and tumor angiogenesis
|
WO2009032693A2
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
EP2195340A4
(en)
|
2007-08-28 |
2011-05-11 |
Uab Research Foundation |
SYNTHETIC APOLIPOPROTEIN E-IMITATING POLYPEPTIDES AND METHOD OF USE
|
WO2010070380A2
(en)
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Doc1 compositions and methods for treating cancer
|
EP2274333A4
(en)
|
2008-03-18 |
2011-06-15 |
Abbott Lab |
PROCESS FOR TREATING PSORIASIS
|
CN102083450A
(zh)
*
|
2008-04-30 |
2011-06-01 |
诺华有限公司 |
致病性构象异构体的分析
|
AU2008360658B2
(en)
|
2008-08-15 |
2015-02-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
S0X9, prostaglandin D2 and retinoic acid for treating pigmentary conditions and melanoma
|
EP4071169A2
(en)
|
2008-08-25 |
2022-10-12 |
Dana Farber Cancer Institute, Inc. |
Conserved influenza hemagglutinin epitope and antibodies thereto
|
MX2011005672A
(es)
*
|
2008-11-28 |
2011-06-20 |
Abbott Lab |
Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
|
WO2010065617A1
(en)
|
2008-12-02 |
2010-06-10 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
CN102630168A
(zh)
|
2009-09-14 |
2012-08-08 |
雅培制药有限公司 |
用于治疗银屑病的方法
|
US20110081293A1
(en)
|
2009-10-07 |
2011-04-07 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
US8912136B2
(en)
|
2009-12-18 |
2014-12-16 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding compounds
|
WO2011088391A2
(en)
|
2010-01-14 |
2011-07-21 |
Haplomics, Inc. |
Predicting and reducing alloimmunogenicity of protein therapeutics
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
CA2793959C
(en)
|
2010-03-25 |
2019-06-04 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
EP2569335B1
(en)
|
2010-05-14 |
2018-08-22 |
Orega Biotech |
Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists
|
US9051619B2
(en)
|
2011-03-25 |
2015-06-09 |
Florida Agricultural and Mechanical University (FAMU) |
Methods and compositions for prostate cancer metastasis
|
HUE037408T2
(hu)
|
2011-06-10 |
2018-08-28 |
Univ Oregon Health & Science |
CMV glikoproteinek és rekombináns vektorok
|
US20130189754A1
(en)
|
2011-09-12 |
2013-07-25 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
WO2013188870A2
(en)
*
|
2012-06-15 |
2013-12-19 |
Beth Israel Deaconess Medical Center, Inc. |
IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
US20140094383A1
(en)
|
2012-10-02 |
2014-04-03 |
Ohio State Innovation Foundation |
Tethered Lipoplex nanoparticle Biochips And Methods Of Use
|
US9783576B2
(en)
|
2013-06-11 |
2017-10-10 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
US9481729B2
(en)
|
2013-09-11 |
2016-11-01 |
The University Of Hong Kong |
Anti-HER2 and anti-IGF-IR BI-specific antibodies and uses thereof
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
US9840555B2
(en)
|
2013-11-04 |
2017-12-12 |
Li-Te Chin |
Method for producing human monoclonal antibodies that binds to at least one part of HMGB1
|
CA2954475C
(en)
|
2014-07-31 |
2023-05-16 |
Uab Research Foundation |
Apoe mimetic peptides and higher potency to clear plasma cholesterol
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
EP3072901A1
(en)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
CA3045756A1
(en)
|
2015-12-05 |
2017-06-08 |
Centre Hospitalier Universitaire Vaudois |
Hiv binding agents
|
EP3523416A4
(en)
|
2016-10-05 |
2020-04-15 |
University of Central Florida Research Foundation, Inc. |
METHODS AND COMPOSITIONS ASSOCIATED WITH ANTI-CANCER THERAPIES OF NK AND ANTI-PDL1 CELLS
|
ES2963635T3
(es)
|
2017-03-28 |
2024-04-01 |
Ohio State Innovation Foundation |
Vacunas de péptido PD1 humano y usos de las mismas
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
US12053523B2
(en)
|
2017-12-13 |
2024-08-06 |
North Carolina State University |
Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
|
US20210260187A1
(en)
|
2018-06-29 |
2021-08-26 |
North Carolina State University |
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
|
WO2020012435A1
(en)
|
2018-07-13 |
2020-01-16 |
Lausanne University Hospital |
Hiv binding agents
|
WO2020139782A1
(en)
|
2018-12-27 |
2020-07-02 |
University Of Utah Research Foundation |
Compositions and methods useful in detecting and treating multiple sclerosis and other demyelinating diseases
|
JP2022523696A
(ja)
*
|
2019-01-28 |
2022-04-26 |
サイフォス、バイオサイエンシズ、インコーポレイテッド |
Car細胞上の非天然nkg2d受容体に、結合した異種分子を選択的に送達する改変非天然nkg2dリガンド
|
EP3986446A1
(en)
|
2019-06-21 |
2022-04-27 |
Vaccinex, Inc. |
Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy
|
EP3996815A2
(en)
|
2019-07-15 |
2022-05-18 |
Lausanne University Hospital |
Hiv binding agents
|
WO2021067550A1
(en)
|
2019-10-02 |
2021-04-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|
KR20210095781A
(ko)
|
2020-01-24 |
2021-08-03 |
주식회사 에이프릴바이오 |
항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
|
JP2023525083A
(ja)
|
2020-05-08 |
2023-06-14 |
ノボキュア ゲーエムベーハー |
多能性幹細胞に交流電場を印加する組成物及び方法
|